Financial News
Headline News about Revance Therapeutics
![](https://cdn.benzinga.com/files/images/story/2023/options_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/healthcare1600.jpg)
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Revance Therapeutics's Future
June 07, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Revance Therapeutics
May 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
7 Analysts Have This to Say About Revance Therapeutics
April 11, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/stock-market-rally-large.jpg)
What 4 Analyst Ratings Have To Say About Revance Therapeutics
January 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/09/aapharma_9.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_132.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/07/biopharma-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/19/logo-evolus-lockup-coral.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_817.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 11, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/Stock_Market_Broker_Analyzing_Graphs_On_Multiple_Computer_Screens._Photo_by_Andrey_Popov_on_Shutterstock.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Intraday Session
January 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/09/image15_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/09/image-tesla4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/09/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7218.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_6014.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5338.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/02/biotech13.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_27899.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/30/jim_cramer_without_logo__tulane_public_relations_by_wikimedia_commons.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_27027.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2022
September 22, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_4069.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16821.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/13/image17_0.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.